Replies to post #503951 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

you aren't going to limit retail because they will only be buying a fraction regardless. You can fill in the blank but I assume NWBO still has to put their signature to the document. That is how contracts work.

[hankmanhub]

This should not really bother you. This sale to Umibe was being contemplated in the context of the previous purchases of Umibe, so NWBO had a fair idea of the order of magnitude of the shares that Umibe might want. They realized that there would be plenty left for other potential C buyers. If in fact he had surprised them and wanted many more shares than previous experience would indicate, they could then always impose a limit on the number of shares they would sell to him.

[Sammy 967]

In my opinion at end of the day company needs money. It doesn’t matter if series C available for big or small investors. It’s clear that first NDA filling going to be in UK. Because there is less politics play in UK than USA-FDA. North west management knows that. So they do need money to do all fillings. Regarding journal I don’t think it’s in management hands. They did theirs work, so now it’s up to journal. Whenever it’s comes out it’s cherry on cake. I don’t think management looking for any partnership or buyout at this time because any offer would be very low at this point. Maybe in future when nwbo going to have all journal article and official nda date out. I am personally been invested in this company for last couple years and will wait as long as it take to finish line. There is no point to complain. If I don’t like the company I would sell and move on. But I believe in science and esteemed doctors behind the company. And management does as much as possible can if you take in consideration how many other companies and people would like nwbo to go bankrupt. It’s just my opinion.